investment.com

Anixa Biosciences Inc — insider transactions

11 transactions on record · ANIX · CIK 715446

Aggregates

computed from the filings below
Purchases, 12m
8
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
2.67
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$139.8K
Sold, 3m
$37.6K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$41.6K
2026-07-20
Director share, 12m
100.0%
of transactions where role is stated
Current run
1 buys
consecutive same-direction transactions
Net 3m flow
$102.2K
purchases minus sales
Total on record
11

Transactions

11 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-032026-07-313KUMAR AMITDirector, Chief Executive OfficerOpen market purchase5,000$3.47$17.4Kfiling
2026-07-292026-07-272Baskies Arnold MDirectorExercise of derivative6,000$3.13$18.8Kfiling
2026-07-292026-07-272Baskies Arnold MDirectorExercise of derivative6,000$0.00—filing
2026-07-292026-07-272Baskies Arnold MDirectorShares withheld for tax5,428$3.46$18.8Kfiling
2026-07-282026-07-271KUMAR AMITDirector, Chief Executive OfficerOpen market purchase5,000$3.44$17.2Kfiling
2026-07-272026-07-243KUMAR AMITDirector, Chief Executive OfficerOpen market purchase3,000$3.73$11.2Kfiling
2026-07-272026-07-270KUMAR AMITDirector, Chief Executive OfficerOpen market purchase3,188$3.37$10.7Kfiling
2026-07-212026-07-201KUMAR AMITDirector, Chief Executive OfficerOpen market purchase5,000$3.46$17.3Kfiling
2026-07-202026-07-200Titterton Lewis H jrDirectorOpen market purchase12,000$3.47$41.6Kfiling
2026-07-162026-07-151Titterton Lewis H jrDirectorOpen market purchase2,797$3.28$9.2Kfiling
2026-07-132026-07-103KUMAR AMITDirector, Chief Executive OfficerOpen market purchase5,000$3.04$15.2Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Anixa Biosciences Inc insider transactions — 11 filings on record — investment.com